FEATURED NEWS

FDA
December 12, 2018
FDA approves TEMIXYS: New HIV Fixed Dose Drug Combination November 27, 2018: FDA recently approved TEMIXYS (lamivudine and tenofovir disoproxil fumarate) tablets, indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 35 kg. TEMIXYS was approved based on two MORE
MATEC
December 12, 2018
GENVOYA renal labeling updates Click here to view full announcement with additional information (webpage) VIREAD HBV label updates (pediatrics) Click here to view full announcement with additional information (website)
MATEC
December 10, 2018
www.matec.info HIV News Alert Updated HHS Perinatal Antiretroviral Treatment Guidelines Released December 7, 2018: The HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission (the Panel) is pleased to announce the release of the updated Recommendations for the Use of Antiretroviral Drugs in Pregnant MORE
MATEC
November 27, 2018
OHIO: Increased HIV Transmission through Injection Drug Use The Ohio Department of Health (ODH) is observing an increase in newly diagnosed HIV infections being reported among persons who inject drugs (PWID). While HIV remains predominantly a sexually transmitted infection, the proportion of cases reporting injection drug use (IDU) as the mode of MORE
MATEC
March 9, 2018
Updates to the Human Papillomavirus Disease Section of the Adult and Adolescent Oppotunistic Infections Guidelines Last updated: March 7, 2018; Last Reviewed: March 7, 2018 The Human Papillomavirus Disease section of the Guidlines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and adolescents was updated on March MORE